Interleukin-10 versus dexamethasone: Effects on polymorphonuclear leukocyte functions of the newborn

Pediatric Research

Volumn 65, Issue 4, 2009, Pages 425-429

  Citarella, Brett V ^b   Miskolci, Veronika ^a,b   Vancurova, Ivana ^b,c   Davidson, Dennis ^a,b  

^a FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH   (United States)

^b SCHNEIDER CHILDREN'S HOSPITAL   (United States)

^c ST JOHN'S UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; DEXAMETHASONE; FORMYLMETHIONYLLEUCYLPHENYLALANINE; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 4; INTERLEUKIN 8; LIPOPOLYSACCHARIDE; PHENYLALANINE; ANTIINFLAMMATORY AGENT; CASP3 PROTEIN, HUMAN; CYTOKINE;

APOPTOSIS; ARTICLE; CELL FUNCTION; CELL KILLING; CESAREAN SECTION; CHEMOTAXIS; CONTROLLED STUDY; CULTURE MEDIUM; CYTOKINE RELEASE; DRUG EFFECT; ENZYME ACTIVITY; HUMAN; IMMUNE FUNCTION TEST; ISOLATION PROCEDURE; NEUTROPHIL; NEWBORN; PHAGOCYTOSIS; PRIORITY JOURNAL; RESPIRATORY BURST; UMBILICAL CORD BLOOD; CELL CULTURE; COMPARATIVE STUDY; CYTOLOGY; CYTOTOXICITY; DOSE RESPONSE; ENZYMOLOGY; FETUS BLOOD; IMMUNOLOGY; METABOLISM; NEUTROPHIL CHEMOTAXIS; TIME;

ANTI-INFLAMMATORY AGENTS; APOPTOSIS; CASPASE 3; CELLS, CULTURED; CHEMOTAXIS, LEUKOCYTE; CYTOKINES; CYTOTOXICITY, IMMUNOLOGIC; DEXAMETHASONE; DOSE-RESPONSE RELATIONSHIP, DRUG; FETAL BLOOD; HUMANS; INFANT, NEWBORN; INTERLEUKIN-10; LIPOPOLYSACCHARIDES; N-FORMYLMETHIONINE LEUCYL-PHENYLALANINE; NEUTROPHIL INFILTRATION; NEUTROPHILS; PHAGOCYTOSIS; RESPIRATORY BURST; TIME FACTORS;

EID: 65349096813     PISSN: 00313998     EISSN: 15300447     Source Type: Journal    
DOI: 10.1203/PDR.0b013e318199384d     Document Type: Article

References (38)

1. Lewis DB, Wilson CB 2006 Developmental immunology and role of host defenses in fetal and neonatal susceptibility to infection. In: Remington J, Klein J, Baker C, Wilson C (eds) Infectious Diseases of the Fetus and Newborn Infant, 6th Ed. Elsevier-Saunders, Philadelphia, pp 149-159
2. Gotsch F, Romero R, Kusanovic JP, Mazaki-Tovi S, Pineles BL, Erez O, Espinoza J, Hassan SS 2007 The fetal inflammatory response syndrome. Clin Obstet Gynecol 50:652-683
3. Watterberg K 2006 Anti-inflammatory therapy in the neonatal intensive care unit: present and future. Semin Fetal Neonatal Med 11:378-384
4. Jones CA, Cayabyab RG, Kwong KY, Stotts C, Wong B, Hamdan H, Minoo P, deLemos RA 1996 Undetectable interleukin (IL)-10 and persistent IL-8 expression early in hyaline membrane disease: a possible developmental basis for the predisposition to chronic lung inflammation in preterm newborns. Pediatr Res 39:966-975
5. McColm JR, Stenson BJ, Biermasz N, McIntosh N 2000 Measurement of interleukin-10 in bronchoalveolar lavage from preterm ventilated infants. Arch Dis Child Fetal Neonatal Ed 82:F156-F159
6. Beresford MW, Shaw NJ 2002 Detectable IL-8 and IL-10 in bronchoalveolar lavage fluid from preterm infants ventilated for respiratory distress syndrome. Pediatr Res 52:973-978
7. Garingo A, Tesoriero L, Cayabyab R, Durand M, Blahnik M, Sardesai S, Ramanathan R, Jones C, Kwong K, Li C, Minoo P 2007 Constitutive IL-10 expression by lung inflammatory cells and risk for bronchopulmonary dysplasia. Pediatr Res 61:197-202
8. Merritt TA, Stuard ID, Puccia J, Wood B, Edwards DK, Finkelstein J, Shapiro DL 1981 Newborn tracheal aspirate cytology: classification during respiratory distress syndrome and bronchopulmonary dysplasia. J Pediatr 98:949-956
9. Huang HC, Tai FY, Wang FS, Liu CA, Hsu TY, Ou CY, Yang KD 2005 Correlation of augmented IL-8 production to premature chronic lung disease: implication of posttranscriptional regulation. Pediatr Res 58:216-221
10. Davidson D, Miskolci V, Clark DC, Dolmaian G, Vancurova I 2007 Interleukin-10 production after pro-inflammatory stimulation of neutrophils and monocytic cells of the newborn. Comparison to exogenous interleukin-10 and dexamethasone levels needed to inhibit chemokine release. Neonatology 92:127-133
11. Kwong KY, Jones CA, Cayabyab R, Lecart C, Khuu N, Rhandhawa I, Hanley JM, Ramanathan R, deLemos RA, Minoo P 1998 The effects of IL-10 on proinflammatory cytokine expression (IL-1beta and IL-8) in hyaline membrane disease (HMD). Clin Immunol Immunopathol 88:105-113
12. Asadullah K, Sterry W, Volk HD 2003 Interleukin-10 therapy - review of a new approach. Pharmacol Rev 55:241-269
13. Urlichs F, Speer CP 2004 Neutrophil function in preterm and term infants. NeoReviews 5:e417-e429
14. Tryzmel J, Miskolci V, Castro-Alcaraz S, Vancurova I, Davidson D 2003 Interleukin-10 inhibits pro-inflammatory chemokine release by neutrophils of the newborn without suppression of nuclear factor-kappa B. Pediatr Res 54:382-386
15. Schild PN, Charles BG 1994 Determination of dexamethasone in plasma of premature neonates using high-performance liquid chromatography. J Chromatogr B Biomed Appl 658:189-192
16. Lugo RA, Nahata MC, Menke JA, McClead RE Jr 1996 Pharmacokinetics of dexamethasone in premature neonates. Eur J Clin Pharmacol 49:477-483
17. Zentay Z, Sharaf M, Qadir M, Drafta D, Davidson D 1999 Mechanism for dexamethasone inhibition of neutrophil migration upon exposure to lipopolysaccharide in vitro: role of neutrophil interleukin-8 release. Pediatr Res 46:406-410
18. Dahlgren C, Karlsson A 1999 Respiratory burst in human neutrophils. J Immunol Methods 232:3-14
19. Ward RA, McLeish KR 1995 Polymorphonuclear leukocyte oxidative burst is enhanced in patients with chronic renal insufficiency. J Am Soc Nephrol 5:1697-1702
20. Green JN, Winterbourn CC, Hampton MB 2007 Analysis of neutrophil bactericidal activity. In: Quinn MT, DeLeo FR, Bokoch GM (eds) Methods in Molecular Biology, Vol 138: Neutrophil Methods and Protocols. Humana Press, Totowa, pp 319-332
21. Castro-Alcaraz S, Miskolci V, Kalasapudi B, Davidson D, Vancurova I 2002 NF-kappa B regulation in human neutrophils by nuclear I kappa B alpha: correlation to apoptosis. J Immunol 169:3947-3953
22. Steel JH, Malatos S, Kennea N, Edwards AD, Miles L, Duggan P, Reynolds PR, Feldman RG, Sullivan MH 2005 Bacteria and inflammatory cells in fetal membranes do not always cause preterm labor. Pediatr Res 57:404-411
23. Barnes PJ 2006 Corticosteroids: the drugs to beat. Eur J Pharmacol 533:2-14
24. Moore KW, de Waal Malefyt R, Coffman RL, O'Garra A 2001 Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 19:683-765
25. Viscardi RM, Muhumuza CK, Rodriguez A, Fairchild KD, Sun CC, Gross GW, Campbell AB, Wilson PD, Hester L, Hasday JD 2004 Inflammatory markers in intrauterine and fetal blood and cerebrospinal fluid compartments are associated with adverse pulmonary and neurologic outcomes in preterm infants. Pediatr Res 55:1009-1017
26. Viscardi RM, Hasday JD, Gumpper KF, Taciak V, Campbell AB, Palmer TW 1997 Cromolyn sodium prophylaxis inhibits pulmonary pro-inflammatory cytokines in infants at high risk for bronchopulmonary dysplasia. Am J Respir Crit Care Med 156:1523-1529
27. Jonsson B, Li YH, Noack G, Brauner A, Tullus K 2000 Downregulatory cytokines in tracheobronchial aspirate fluid from infants with chronic lung disease of prematurity. Acta Paediatr 89:1375-1380
28. Reglier H, Arce-Vicioso M, Fay M, Gougerot-Pocidalo MA, Chollet-Martin S 1998 Lack of IL-10 and IL-13 production by human polymorphonuclear neutrophils. Cytokine 10:192-198
29. Vicioso MA, Garaud JJ, Reglier-Poupet H, Lebeaut A, Gougerot-Pocidalo MA, Chollet-Martin S 1998 Moderate inhibitory effect of interleukin-10 on human neutrophil and monocyte chemotaxis in vitro. Eur Cytokine Netw 9:247-253
30. Bussolati B, Mariano F, Montrucchio G, Piccoli G, Camussi G 1997 Modulatory effect of interleukin-10 on the production of platelet-activating factor and superoxide anions by human leucocytes. Immunology 90:440-447
31. Reglier-Poupet H, Hakim J, Gougerot-Pocidalo MA, Elbim C 1998 Absence of regulation of human polymorphonuclear oxidative burst by interleukin-10, interleukin-4, interleukin-13 and transforming growth factor-beta in whole blood. Eur Cytokine Netw 9:633-638
32. Ballabh P, Simm M, Kumari J, Califano C, Aghai Z, Laborada G, Sison C, Cunningham-Rundles S 2003 Respiratory burst activity in bronchopulmonary dysplasia and changes with dexamethasone. Pediatr Pulmonol 35:392-399
33. Kotecha S, Mildner RJ, Prince LR, Vyas JR, Currie AE, Lawson RA, Whyte MK 2003 The role of neutrophil apoptosis in the resolution of acute lung injury in newborn infants. Thorax 58:961-967
34. Grigg JM, Savill JS, Sarraf C, Haslett C, Silverman M 1991 Neutrophil apoptosis and clearance from neonatal lungs. Lancet 338:720-722
35. Cox G 1995 Glucocorticoid treatment inhibits apoptosis in human neutrophils. Separation of survival and activation outcomes. J Immunol 154:4719-4725
36. Ward C, Murray J, Clugston A, Dransfield I, Haslett C, Rossi AG 2005 Interleukin-10 inhibits lipopolysaccharide-induced survival and extracellular signal-regulated kinase activation in human neutrophils. Eur J Immunol 35:2728-2737
37. Coldren CD, Nick JA, Poch KR, Woolum MD, Fouty BW, O'Brien JM, Gruber MP, Zamora MR, Svetkauskaite D, Richter DA, He Q, Park JS, Overdier KH, Abraham E, Geraci MW 2006 Functional and genomic changes induced by alveolar transmigration in human neutrophils. Am J Physiol Lung Cell Mol Physiol 291:L1267-L1276
38. Ballabh P, Simm M, Kumari J, Krauss AN, Jain A, Califano C, Lesser ML, Cunningham-Rundles S 2004 Neutrophil and monocyte adhesion molecules in bronchopulmonary dysplasia, and effects of corticosteroids. Arch Dis Child Fetal Neonatal Ed 89:F76-F83